A randomized, double-blind. placebo-controlled trial of modulating the gut microbiome is successful for symptom alleviation in Long Covid www.thelancet.com/journals/lan...
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2022 – Oct 2025Where it's discussed
-
Bluesky25 posts
-
X / Twitter13 posts
-
Facebook3 posts
-
YouTube2 videos
-
News2 articles
-
Blogs2 articles
AI synopsis
What people are saying
The overall tone indicates a balanced recognition of the trial’s findings, with comments like 'supports previous evidence' and mentioning the importance of rigorous methodology. The language used is straightforward, reflecting an academic or clinical tone, and the discussion revolves around the implications for treatment of myasthenia gravis, signaling a moderate yet meaningful impact in the medical community.
Most discussions acknowledge the study's findings that immunoglobulin did not significantly reduce corticosteroid use, reflecting a generally aligned view on its limited efficacy.
Some discussions show neutral or minimal curiosity, with a few posts simply referencing the study without deep analysis or emotional tone.
Several posts engage with the research by mentioning the methodology or implications, such as emphasizing the trial's design or discussing its clinical significance.
The discussions suggest moderate impact, recognizing that the study contributes valuable data to treatment debates, though it does not seem to dramatically shift current perceptions.
Abstract in brief
- This study tested whether immunoglobulin (IGIVC) could help people with myasthenia gravis (MG) reduce their corticosteroid (CS) doses.
- The results showed that IGIVC did not significantly decrease CS doses more than a placebo, and both treatments were generally well tolerated.
- Overall, IGIVC was not more effective than placebo in reducing corticosteroid use in MG patients, indicating that their mechanisms might differ.]
Top posts
Most liked on X and BlueskyStudy: A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 Published: 01 August 2025 www.nature.com/articles/s41...
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID
New from #Transfusion Evidence Library: Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding by Prasad et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky
From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in #MyastheniaGravis by Bril et al. https://t.co/DtOax3zNCF https://t.co/kZTAIKq1hq
What were the results of a randomized, double-blind, placebo-controlled trial of a daily half teaspoon of powdered black cumin in Hashimoto’s patients?
All mentions
Immunoglobulin Efficacy in Reducing Corticosteroid Use in Myasthenia Gravis
This study tested whether immunoglobulin could help people with myasthenia gravis reduce their corticosteroid doses. The results showed that IGIVC did not significantly decrease CS doses more than a placebo, and both…
Immunoglobulin's Role as a Corticosteroid-Sparing Treatment in Myasthenia Gravis
Dr Gordon Smith and Dr Vera Bril discuss a study on the effectiveness of immunoglobulin in reducing corticosteroid use in Myasthenia Gravis patients. The trial found no significant difference between immunoglobulin and…
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID
Lactucin, the hypnotic component of lettuce, is put to the test in a randomized, double-blind, placebo-controlled trial of lettuce seeds.
I patiently await the randomized double blind placebo-controlled trial of bottle of Jagermeister for breakfast, 8 ball of meth for lunch, and a vegan shake for dinner w/ no artificial dyes versus placebo WTF
New from #Transfusion Evidence Library: Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding by Prasad et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky
A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Intracisternal Engineered Autologous Exosomes (NV-101) to Restore Neuronal Proteostasis in Early Alzheimer's Disease: The RESTORE Protocol #NeuroDegeneration
A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Intracisternal Engineered Autologous Exosomes (NV-101) to Restore Neuronal Proteostasis in Early Alzheimer's Disease: The RESTORE Protocol https://www.medrxiv.org/content/10.1101/2025.09.04.25335118v1
Do omega 3 supplements actually do anything for people with MS? This Randomized, Double-Blind, Placebo-Controlled Trial of DHA + EPA found no statistically significant difference in relapses, MRI lesions, disability progression, quality of life, or fatigue jamanetwork.com/journals/jam...
Study: A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 Published: 01 August 2025 www.nature.com/articles/s41...
A randomized, double-blind, placebo-controlled trial of #niclosamide nanohybrid for #treatment of patients with mild to moderate #COVID19, etidiohnew.blogspot.com/2025/08/a-ra...
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 ->Nature | #Covid19 | More info from EcoSearch
What were the results of a randomized, double-blind, placebo-controlled trial of a daily half teaspoon of powdered black cumin in Hashimoto’s patients?
A randomized, double‐blind, placebo‐controlled trial of abatacept for the treatment of relapsing, non‐severe, granulomatosis with polyangiitis - Langford - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitis
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granu… pubmed.ncbi.nlm.nih.gov/40506793/
A Randomized, Double-blind, Placebo-Controlled Trial of Terminalia Chebula and Terminalia Bellerica For Hyperuricemia www.thefocalpoints.com/p/a-randomiz...
A randomized, double-blind, placebo controlled trial of IL-7 in critically ill COVID-19 patients revealed reduced nosocomial infections insight.jci.org/articles/vie... @jci-insight.bsky.social
Open Access UCL Research: IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab discovery.ucl.ac.uk/id/eprint/10...
2/ DEFEaT -AKI WAS Phase Il, randomized, double blind, placebo-controlled trial of IV deferoxamine in patients undergoing CABG or valve surgery with CPB #kidneywk
3/ FINEARTS-HF Study Design Randomized, double-blind, placebo-controlled trial of patients with HFmrEF/HFpEF Inclusion and exclusion criteria #KidneyWk
A randomized, double-blind. placebo-controlled trial of modulating the gut microbiome is successful for symptom alleviation in Long Covid www.thelancet.com/journals/lan...
RT @Myasthenie_AMIS: Echos de la recherche • [Pubmed] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effect…
Echos de la recherche • [Pubmed] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Mya https://t.co/Wo1zKEdXaT
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis | Neurology https://t.co/O6mWtqUf7U
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis | Neurology https://t.co/O6mWtqUf7U
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis - AAN Neurology via BrainSights for iOS https://t.co/rR5Z27ZLe8
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis - https://t.co/jE2iEpwGny
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/kJyIAmkzJk #neurology #doctors #medtwitter #medical #medicinenews #healthcare
RT @TransfusionLib: From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticost…
From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in #MyastheniaGravis by Bril et al. https://t.co/DtOax3zNCF https://t.co/kZTAIKq1hq
A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/V7QM4z4TfB
RT @Myasthenie_AMIS: Echos de la recherche • [Pubmed] A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Ef…
Echos de la recherche • [Pubmed] A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in https://t.co/If2pdB6Y7x
New article: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/gFrpbnTYd7 #MG #myastheniagravis #neurology https://t.co/b2yrGswFZK